Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: Schizophr Res. 2023 Dec 21;264:140–146. doi: 10.1016/j.schres.2023.12.022

Table 2:

Predictors of relapse in 12 months after discharge

OR p-value 95% CI
Any relapse 12 months before ending CSC 4.69 0.002 1.78 12.34
Months in CSC 1.004 0.87 0.96 1.05
Non-White race 0.89 0.80 0.36 2.22
Male sex 0.53 0.23 0.18 1.52
Non-English speaking 1.32 0.69 0.34 5.18
#months with antipsychotic fill 1.07 0.33 0.93 1.24
Age at exit 0.96 0.45 0.85 1.08
Cannabis use at last CSC contact 4.06 0.004 1.56 10.56
Schizophrenia or schizoaffective disorder diagnosis 1.01 0.99 0.35 2.9
Alcohol use at exit 1.491 0.59 0.35 6.34
Insurance
Medicaid 0.71 0.50 0.27 1.92
Medicare 0.81 0.88 0.055 12.07
Private Insurance (comparator) 1 . . .
No insurance 2.01 0.53 0.22 18.05